Spotlight on Impactful Research: Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Liver Transplantation Recipients. Clin Liver Dis (Hoboken) 2021 Feb;17(2):53-56
Date
03/09/2021
Pubmed ID
33680435Pubmed Central ID
PMC7916437DOI
10.1002/cld.962Scopus ID
2-s2.0-85101797858 (requires institutional sign-in at Scopus site)
Author List
Loy V
Author
Veronica Loy DO Associate Professor in the Medicine department at Medical College of Wisconsin